CTNI-47. TUMOR TREATING FIELDS COMBINE WITH TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA: A RETROSPECTIVE ANALYSIS OF CHINESE PATIENTS
Zhiyong Qin(Fudan University), Jigntao Nie, Jinsong Wu(Shanghai Medical College of Fudan University), Dongxiao Zhuang(Shanghai Center for Brain Science and Brain-Inspired Technology), Lingchao Chen(Allen Institute for Brain Science), Junrui Chen(Huashan Hospital), Yu Yao(Qinghai University)
Cited by 0
Related Papers
CGCG clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2016|650
Clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2020|482
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
|The Lancet Oncology|2016|374
Temozolomide-associated hypermutation in gliomas
|Neuro-Oncology|2018|227
Adult IDH wild-type lower-grade gliomas should be further stratified
|Neuro-Oncology|2017|222